178 related articles for article (PubMed ID: 23904470)
1. Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial.
Baker JF; Ostergaard M; Emery P; Hsia EC; Lu J; Baker DG; Conaghan PG
Ann Rheum Dis; 2014 Nov; 73(11):1968-74. PubMed ID: 23904470
[TBL] [Abstract][Full Text] [Related]
2. Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients.
Østergaard M; Emery P; Conaghan PG; Fleischmann R; Hsia EC; Xu W; Rahman MU
Arthritis Rheum; 2011 Dec; 63(12):3712-22. PubMed ID: 22127693
[TBL] [Abstract][Full Text] [Related]
3. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
[TBL] [Abstract][Full Text] [Related]
4. MRI-detected subclinical joint inflammation is associated with radiographic progression.
Krabben A; Stomp W; van Nies JA; Huizinga TW; van der Heijde D; Bloem JL; Reijnierse M; van der Helm-van Mil AH
Ann Rheum Dis; 2014 Nov; 73(11):2034-7. PubMed ID: 25074691
[TBL] [Abstract][Full Text] [Related]
5. Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years.
Baker JF; Ostergaard M; George M; Shults J; Emery P; Baker DG; Conaghan PG
Ann Rheum Dis; 2014 Nov; 73(11):1923-8. PubMed ID: 25091439
[TBL] [Abstract][Full Text] [Related]
6. Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis.
Emery P; van der Heijde D; Ostergaard M; Conaghan PG; Genovese MC; Keystone EC; Fleischmann R; Hsia EC; Xu W; Xu S; Rahman MU
Ann Rheum Dis; 2011 Dec; 70(12):2126-30. PubMed ID: 21926186
[TBL] [Abstract][Full Text] [Related]
7. Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial.
Conaghan PG; Emery P; Østergaard M; Keystone EC; Genovese MC; Hsia EC; Xu W; Rahman MU
Ann Rheum Dis; 2011 Nov; 70(11):1968-74. PubMed ID: 21784729
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI.
Gandjbakhch F; Foltz V; Mallet A; Bourgeois P; Fautrel B
Ann Rheum Dis; 2011 Dec; 70(12):2159-62. PubMed ID: 21859693
[TBL] [Abstract][Full Text] [Related]
9. MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression.
Bøyesen P; Haavardsholm EA; Ostergaard M; van der Heijde D; Sesseng S; Kvien TK
Ann Rheum Dis; 2011 Mar; 70(3):428-33. PubMed ID: 20810395
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression.
Haavardsholm EA; Bøyesen P; Østergaard M; Schildvold A; Kvien TK
Ann Rheum Dis; 2008 Jun; 67(6):794-800. PubMed ID: 17981915
[TBL] [Abstract][Full Text] [Related]
11. Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques.
Conaghan PG; Østergaard M; Bowes MA; Wu C; Fuerst T; van der Heijde D; Irazoque-Palazuelos F; Soto-Raices O; Hrycaj P; Xie Z; Zhang R; Wyman BT; Bradley JD; Soma K; Wilkinson B
Ann Rheum Dis; 2016 Jun; 75(6):1024-33. PubMed ID: 27002108
[TBL] [Abstract][Full Text] [Related]
12. Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis.
Baker JF; Conaghan PG; Emery P; Baker DG; Østergaard M
Ann Rheum Dis; 2016 Jun; 75(6):1114-9. PubMed ID: 26091907
[TBL] [Abstract][Full Text] [Related]
13. Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years' functional and radiographic outcome in early rheumatoid arthritis.
Hetland ML; Østergaard M; Stengaard-Pedersen K; Junker P; Ejbjerg B; Jacobsen S; Ellingsen T; Lindegaard H; Pødenphant J; Vestergaard A; Jurik AG; Krogh NS; Hørslev-Petersen K;
Scand J Rheumatol; 2019 Jan; 48(1):1-8. PubMed ID: 30101636
[TBL] [Abstract][Full Text] [Related]
14. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study.
Døhn UM; Ejbjerg B; Boonen A; Hetland ML; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller JM; Ostergaard M
Ann Rheum Dis; 2011 Feb; 70(2):252-8. PubMed ID: 20980282
[TBL] [Abstract][Full Text] [Related]
15. Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
Hetland ML; Stengaard-Pedersen K; Junker P; Østergaard M; Ejbjerg BJ; Jacobsen S; Lottenburger T; Hansen I; Tarp U; Andersen LS; Svendsen A; Pedersen JK; Lauridsen UB; Ellingsen T; Lindegaard H; Pødenphant J; Vestergaard A; Jurik AG; Hørslev-Petersen K;
Ann Rheum Dis; 2010 Oct; 69(10):1789-95. PubMed ID: 20444751
[TBL] [Abstract][Full Text] [Related]
16. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.
Forslind K; Svensson B
Scand J Rheumatol; 2016; 45(2):99-102. PubMed ID: 26313244
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: a study of patients receiving combined anakinra and methotrexate treatment.
Østergaard M; Duer A; Nielsen H; Johansen JS; Narvestad E; Ejbjerg BJ; Baslund B; Møller JM; Thomsen HS; Petersen J
Ann Rheum Dis; 2005 Oct; 64(10):1503-6. PubMed ID: 15778238
[TBL] [Abstract][Full Text] [Related]
18. Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study.
Palosaari K; Vuotila J; Takalo R; Jartti A; Niemelä RK; Karjalainen A; Haapea M; Soini I; Tervonen O; Hakala M
Rheumatology (Oxford); 2006 Dec; 45(12):1542-8. PubMed ID: 16670155
[TBL] [Abstract][Full Text] [Related]
19. Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up study.
Lindegaard HM; Vallø J; Hørslev-Petersen K; Junker P; Østergaard M
Ann Rheum Dis; 2006 Sep; 65(9):1208-12. PubMed ID: 16540550
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement.
McQueen FM; Stewart N; Crabbe J; Robinson E; Yeoman S; Tan PL; McLean L
Ann Rheum Dis; 1999 Mar; 58(3):156-63. PubMed ID: 10364913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
